Lineage Cell Therapeutics
  • Company
    • About Us
    • Leadership
    • Board of Directors
    • Careers
    • Contact
  • Pipeline
    • Overview
    • OpRegen® (Dry AMD)
    • OPC1 (Spinal Cord Injury)
    • VAC2 (Immuno-oncology)
  • Technology
    • Lineage Platform
    • Manufacturing
  • Media
  • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Charters and Documents
      • Leadership
      • Board of Directors
      • Committee Composition
    • Analyst Coverage
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
    • Financials & Filings
      • SEC Filings
      • Annual Report and Proxy Information
      • 2018 AgeX Form 10 and Information Statement
      • 2019 Form 8937
    • E-mail Alerts
    • Contact IR
  • Menu Menu
December 10, 2021/by lineagethera
https://lineagecell.com/wp-content/uploads/2022/04/platform8.png 732 1868 lineagethera https://lineagecell.com/wp-content/uploads/2019/05/LINEAGE_NEGATIVE_1800x360-1030x206.png lineagethera2021-12-10 11:15:492022-04-29 16:15:38
© Copyright - Lineage Cell Therapeutics, Inc.   |   Terms of Use & Privacy   |   [email protected]
  • Facebook
  • Twitter
  • LinkedIn
Scroll to top